The Indian Council of Medical Research (ICMR) has obtained permission for “restricted use in public health emergency” of two second-line HIV medications for use against the novel coronavirus (nCoV)
Launching the “Beti Bachao, Beti Padhao” scheme on Thursday, Prime Minister Narendra Modi denounced the practice of female foeticide, saying such discrimination reflects “mental illness” and displa
With an eye on polio free status from the World Health Organisation next January, the Health Ministry wants travellers from seven countries — three where polio is endemic and four which have seen r
New Delhi : In an article printed this week, British Medical Journal has raised questions about the safety of a class of “new-age” drugs touted not only as a wonder cure for type 2 diabetes but als
After bandying its Rs 6,000-crore a year scheme to provide free generic drugs at government health centres and hospitals for a year, the health ministry has now shelved the plan.
Often criticised for its dismal efforts in preventing infant deaths, India, according to the latest Sample Registration System (SRS) data, has succeeded in reducing deaths of newborns aged 28 days or less.
The data shows that in 2011, the country's neonatal mortality rate (NMR) stood at 31 per 1,000 live births, down six per cent from 33 in 2010. The figure had remained at 37 for the period 2004-07.
The "zero-calorie" artificial sweetener has gone sour. The sweetener which became quite popular over the past decade has been found to increase blood sugar, making it anything but safe for diabetics, its USP.
Researchers at the Washington University School of Medicine have found that "zero-calorie" sucralose — marketed as splenda, sucra plus and said to be twice as sweet as saccharine and three times as sweet as aspartame — is not metabolically inert as was believed and instead raises blood sugar. It does so possibly by acting on receptors in intestines that mediate uptake of glucose into blood, thereby rendering them more efficient.
